Lifeward Stock Scheduled to Reverse Split on Tuesday, February 24th (NASDAQ:LFWD)

Lifeward Ltd. (NASDAQ:LFWD) shares are scheduled to reverse split on Tuesday, February 24th. The 1-12 reverse split was announced on Friday, February 20th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, February 23rd.

Lifeward Stock Down 18.3%

LFWD traded down $0.09 during trading on Friday, reaching $0.43. 1,073,509 shares of the company’s stock were exchanged, compared to its average volume of 350,421. The company has a market capitalization of $7.78 million, a P/E ratio of -0.14 and a beta of 0.16. The business has a 50 day moving average price of $0.61 and a 200 day moving average price of $0.63. Lifeward has a fifty-two week low of $0.40 and a fifty-two week high of $2.95.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on LFWD shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Lifeward in a research report on Thursday, January 22nd. HC Wainwright lowered their price objective on Lifeward from $13.00 to $4.50 and set a “buy” rating on the stock in a research note on Tuesday, November 18th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $4.25.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. HRT Financial LP grew its position in Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the last quarter. Jane Street Group LLC increased its stake in shares of Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares in the last quarter. Finally, Citadel Advisors LLC increased its stake in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after buying an additional 198,406 shares in the last quarter. Institutional investors own 26.76% of the company’s stock.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.